Effect of a sodium-channel activator (BDF 9148) on insulin secretion in mouse pancreatic islets

Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):417-21. doi: 10.1007/pl00004963.

Abstract

The interplay of the ion channels of the pancreatic beta-cell is a crucial step in the regulation of insulin secretion. Though the presence of sodium channels is obvious in the pancreatic beta-cell, their role is not yet understood. Using a specific modulator of sodium channels. BDF 9148, a concentration-dependent reduction of glucose-stimulated insulin release was found. BDF 9148 also reduced tolbutamide- or potassium chloride-induced insulin release. BDF 9148 had no effect on KATP channel function as estimated by 86Rb+ efflux measurement and was also ineffective on 45Ca2+ uptake but augmented 22Na+ uptake. BDF 9148 did not alter the electrical activity of beta-cells significantly. Since BDF 9148 antagonized the stimulatory effect of veratridine on insulin release, sodium channels are likely to be the target of its action. In conclusion, the sodium-channel modulator BDF 9148 inhibits nutrient-induced insulin release by a mechanism which is not involved in the generation of action potentials in the beta-cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azetidines / pharmacology*
  • Calcium Radioisotopes / metabolism
  • Cardiotonic Agents / pharmacology*
  • Electrophysiology
  • Female
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / cytology
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Mice
  • Rubidium Radioisotopes
  • Sodium Channels / drug effects*
  • Sodium Radioisotopes
  • Veratridine / pharmacology

Substances

  • Azetidines
  • Calcium Radioisotopes
  • Cardiotonic Agents
  • Insulin
  • Rubidium Radioisotopes
  • Sodium Channels
  • Sodium Radioisotopes
  • BDF 9148
  • Veratridine